Format: Article
Author: CB Insights
Title: Microbiome Personalization Could Reshape Health And Wellness
Year: 2020 (February, 6)
Short summary:
1. Microbiome test (MB) – is a DNA sequencing of all the microorganisms that inhabit the gastrointestinal (GI) tract
2. The global MB market is expected to be worth over $11,35 bln at 2027 with CAGR 7,2% (2021-2027)
3. MB already helps to customize treatment of type 2 diabetes and GI disorders. Studies on sleep disorders, obesity, depression and autism spectrum disorder (ASD) are undergo
4. Most current services try to combine in a monthly subscription:
1. Diagnostics: MB with DNA-test (human genome), questionnaire & blood test
2. Treatment: consultations, customized apps, "food as medicine", supplements and lifestyle
Full summary: https://t.me/asobepanek
#summary, #future, #cbinsights, #health, #HealthTech, #biotech, #microbiome, #dna, #biohacking, #longevity, #transhumanism
#wellness #food #sleep #personalization #sleep #medicine
